Insider Stock Trading History of Medimmune Ventures, Inc.


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Medimmune Ventures, Inc. since year 2005. The trader's CIK number is 1291884. At the time of this reporting, Medimmune Ventures, Inc. is the 10% Owner of G1 Therapeutics, Inc. . (stock ticker symbol GTHX). See this page for all insider trading activities at G1 Therapeutics, Inc. .

Note that in the past MedImmune Ventures, Inc. also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Medimmune Ventures, Inc. since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-12-15 GTHX G1 Therapeutics, Inc. Sale 200,000 19.75 3,950,000
2017-12-01 GTHX G1 Therapeutics, Inc. Sale 133,906 19.75 2,644,643
2017-11-20 GTHX G1 Therapeutics, Inc. Sale 200,000 20.01 4,002,000
2017-05-22 GTHX G1 Therapeutics, Inc. Buy 75,000 15.00 1,125,000
2015-06-30 CATB Catabasis Pharmaceuticals Inc Buy 223,439 12.00 2,681,268
2015-02-23 ITEK Inotek Pharmaceuticals Corp Buy 416,667 6.00 2,500,002
2014-04-01 AGTC Applied Genetic Technologies Corp Buy 75,735 12.00 908,820

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Medimmune Ventures, Inc. (10% Owner of G1 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.